Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (101-110 of 275) with videos related to

Pageof 28
Sort By:
Cancer|May 13, 2006
Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinomaHillary L Copp, Joseph L Chin, Mark Conaway, et al.
Scientific Reports|September 9, 2015
A whole-genome RNAi screen uncovers a novel role for human potassium channels in cell killing by the parasite Entamoeba histolyticaChelsea Marie, Hans P Verkerke, Dan Theodorescu, et al.
Oncology (Williston Park, N.Y.)|January 4, 2018
Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular MarkersTahlita C M Zuiverloon, Florus C de Jong, Dan Theodorescu
European Urology|April 23, 2003
The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapyTracey Krupski, Eric A Bissonette, Gina R Petroni, et al.
Journal of Theoretical Biology|September 3, 2011
In vitro transcriptomic prediction of hepatotoxicity for early drug discoveryFeng Cheng, Dan Theodorescu, Ira G Schulman, et al.
Cancer Research|October 21, 2011
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancersGarrett M Dancik, Yuanbin Ru, Charles R Owens, et al.
Urology|October 19, 2002
Perioperative costs and charges of prostate brachytherapy and prostatectomyAntoine A Makhlouf, James C Boyd, Terrence N Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approachBrian Nicholson, Kathryn Gulding, Mark Conaway, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancerSophie G Fletcher, Stacey E Mills, Mark E Smolkin, et al.
Urology|February 25, 2003
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive surveyJoshua D Hall, James C Boyd, Marguerite C Lippert, et al.
Pageof 28

Showing results (101-110 of 275) with videos related to

Sort By:
Pageof 28
Cancer|May 13, 2006
Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinomaHillary L Copp, Joseph L Chin, Mark Conaway, et al.
Scientific Reports|September 9, 2015
A whole-genome RNAi screen uncovers a novel role for human potassium channels in cell killing by the parasite Entamoeba histolyticaChelsea Marie, Hans P Verkerke, Dan Theodorescu, et al.
Oncology (Williston Park, N.Y.)|January 4, 2018
Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular MarkersTahlita C M Zuiverloon, Florus C de Jong, Dan Theodorescu
European Urology|April 23, 2003
The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapyTracey Krupski, Eric A Bissonette, Gina R Petroni, et al.
Journal of Theoretical Biology|September 3, 2011
In vitro transcriptomic prediction of hepatotoxicity for early drug discoveryFeng Cheng, Dan Theodorescu, Ira G Schulman, et al.
Cancer Research|October 21, 2011
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancersGarrett M Dancik, Yuanbin Ru, Charles R Owens, et al.
Urology|October 19, 2002
Perioperative costs and charges of prostate brachytherapy and prostatectomyAntoine A Makhlouf, James C Boyd, Terrence N Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approachBrian Nicholson, Kathryn Gulding, Mark Conaway, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancerSophie G Fletcher, Stacey E Mills, Mark E Smolkin, et al.
Urology|February 25, 2003
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive surveyJoshua D Hall, James C Boyd, Marguerite C Lippert, et al.
Pageof 28